OBIO® Drives AI Innovation in Critical Care with The Ottawa Hospital’s Use of the Extubation Advisor

TORONTO – OBIO®, through the Biotechnology and Life Sciences Commercialization Center of Excellence (LSCTC), supports the Extubation Consultant (EA) accreditation at The Ottawa Hospital (TOH). The AI-powered clinical support tool was developed by Canadian company Therapeutic Monitoring Systems Inc. (TMS), to assist physicians in making extubation decisions in intensive care units.

EA is certified after completing successful evaluations at TOH and Unity Health through OBIO’s Early Adopter Health Network (EAHN) program. EAHN is supported by the Canadian Government through Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and LSCTC is supported by the Government of Ontario.

Removing a patient from mechanical ventilation, known as extubation, is a complex process in critical care. The EA, based on research by Dr. Andrew J. E. Seely, a thoracic surgeon and intensive care unit (ICU) physician at TOH and CEO of TMS, uses artificial intelligence to analyze a patient’s respiratory data and help doctors make extubation decisions. This reduces uncertainty by identifying patients at higher or lower risk for extubation failure, leading to better patient outcomes and more efficient use of ICU resources.

said Dr. Seely, CEO of Therapeutic Monitoring Systems (TMS) and Chief of Thoracic Surgery at TOH.

TOH is one of the first hospitals to implement EA as part of a real-world evaluation. This technology complements existing clinical judgment by providing personalized, data-driven insights that may help reduce ICU lengths of stay and reduce ventilation-related complications.

said Dr. Kwadwo Kyeremanteng, chief of critical care at The Ottawa Hospital.

EA has received regulatory clearance from both Health Canada and the European Union. TMS is now working with additional healthcare partners in Canada and internationally to expand its use and widespread adoption.

said Dr. Maura Campbell, President and CEO of OBIO®.

said the Honorable Ivan Solomon, Minister of Artificial Intelligence and Digital Innovation and Minister Responsible for the Federal Economic Development Agency for Southern Ontario.

Therapeutic Monitoring Systems (TMS), a Canadian company based in Ottawa, Ontario, Canada, develops regulatory-approved predictive clinical decision support software (CDSS) tools.

TMS is transforming the way patient monitoring data is used to significantly improve patient care, by converting contrast waveforms (such as EKG) (using variance analysis) into predictive CDSSs (using AI machine learning), which are then implemented at the bedside of acutely ill patients in the intensive care unit (ICU) and emergency department (ED).

TMS’s patented software technology combines waveform processing, variance analysis, and predictive modeling to convert routinely collected (and routinely discarded) waveforms into a measure of the risk of subsequent deterioration for an individual patient. TMS provides predictive support for bedside clinical decisions in a targeted manner to address unresolved issues, with low variability providing a sensitive measure of the severity of a patient’s illness and/or frailty. TMS CDSS tools are integrated with existing care delivery processes, thus providing clinical decision support at the time clinicians make the decision. TMS CDSS tools are designed to enhance the effectiveness of treatment plans and reduce harmful and costly adverse events.

TMS is collaborating with OBS Medical, the Ottawa Hospital Research Institute (OHRI) and clinicians and scientists globally to research, develop and commercialize this new technology, to help transform monitoring and improve care.

To learn more, visit: therapeutic monitoring.com.

The Ottawa Hospital (TOH) is one of Canada’s premier teaching and research hospitals where we are guided by our vision to provide our loved ones with the world-class, compassionate care we all desire. Our multi-campus hospital, affiliated with the University of Ottawa, is home to an internationally accredited Regional Trauma Centre, Cancer Centre, and Discovery Center.